rf-fullcolor.png

 

February 21, 2018
by Zachary Brennan

India’s Drug Regulator Sees Top-Level Shakeup

GN Singh, the Drug Controller General of India (DCGI) since 2012, has been relieved of his post, according to a circular distributed by India’s Ministry of Health and Family Welfare.

India’s Central Drugs Standard Control Organization (CDSCO) announced on Twitter that S. Eswara Reddy will take over as DCGI, though media reports said he will only be in the job for the next three months until a permanent appointment is made.

Meanwhile, CDSCO announced via an order on Tuesday that 42 drug inspectors and technical officers would be transferred, many from CDSCO’s headquarters, to various zones across the subcontinent.

CDSCO said the transfers are being made to strengthen the various zones and sub-zones.

On Monday, CDSCO also held a workshop for device manufacturers to discuss the regulator’s new online portal. And next Monday, the Pharmaceuticals Export Promotion Council of India is meeting with regulators from the UK’s Medicines and Healthcare products Regulatory Agency.
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.